scholarly article | Q13442814 |
P356 | DOI | 10.1007/S00296-016-3556-6 |
P698 | PubMed publication ID | 27577941 |
P2093 | author name string | Zlatimir Kolarov | |
Todor Kundurzhiev | |||
Mariana Ivanova | |||
Atanas Kundurdjiev | |||
Rada Gancheva | |||
P2860 | cites work | Uric acid as an independent risk factor in the treatment of hypertension | Q77206589 |
Uric acid in chronic heart failure: a marker of chronic inflammation | Q77788323 | ||
Uric acid and cardiovascular risk | Q79689991 | ||
Relation of left ventricular hypertrophy with systemic inflammation and endothelial damage in resistant hypertension | Q80627954 | ||
Independent impact of gout on mortality and risk for coronary heart disease | Q80795931 | ||
Serum uric acid is associated with microalbuminuria and subclinical atherosclerosis in men with type 2 diabetes mellitus | Q81169690 | ||
Diversity of denizens of the atherosclerotic plaque: not all monocytes are created equal | Q81508508 | ||
Prediction of cardiovascular morbidity and mortality: comparison of the internal carotid artery resistive index with the common carotid artery intima-media thickness | Q82388741 | ||
Cellular characterization of the gouty tophus: a quantitative analysis | Q82777842 | ||
Elevated serum uric acid is an independent predictor for cardiovascular events in patients with severe coronary artery stenosis: subanalysis of the Japanese Coronary Artery Disease (JCAD) Study | Q83592216 | ||
The effects of gout on left atrial volume remodelling: a prospective echocardiographic study | Q87063317 | ||
Gout and the risk of acute myocardial infarction | Q28199792 | ||
Inflammation in atherosclerosis | Q29547428 | ||
K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification | Q29547560 | ||
Gout and the risk for incident heart failure and systolic dysfunction | Q30505423 | ||
Hyperuricaemia, chronic kidney disease, and outcomes in heart failure: potential mechanistic insights from epidemiological data | Q33784030 | ||
Left ventricular hypertrophy: major risk factor in patients with hypertension: update and practical clinical applications | Q34200319 | ||
Relationship between serum uric acid and internal carotid resistive index in hypertensive women: a cross-sectional study | Q34338766 | ||
Anemia as a risk factor for cardiovascular disease in The Atherosclerosis Risk in Communities (ARIC) study | Q34525035 | ||
Clinical application of C-reactive protein for cardiovascular disease detection and prevention | Q35054464 | ||
Reduced creatinine clearance is associated with early development of subcutaneous tophi in people with gout | Q35073601 | ||
Review. The resistive index in renal Doppler sonography: where do we stand? | Q35088758 | ||
Serum uric acid level and its association with metabolic syndrome and carotid atherosclerosis in patients with type 2 diabetes | Q35184941 | ||
Cardiovascular risk factors and comorbidities in patients with hyperuricemia and/or gout: a systematic review of the literature | Q35236580 | ||
Observations on Certain Pathological Conditions of the Blood and Urine in Gout, Rheumatism and Bright's Disease | Q36182898 | ||
A clinician's guide to tissue Doppler imaging. | Q36420143 | ||
Serum uric acid is associated with carotid plaques: the National Heart, Lung, and Blood Institute Family Heart Study. | Q37317340 | ||
Ultrasound Doppler renal resistive index: a useful tool for the management of the hypertensive patient | Q37403292 | ||
Value and limitations of existing scores for the assessment of cardiovascular risk: a review for clinicians. | Q37602789 | ||
Inflammation, oxidative stress and lipids: the risk triad for atherosclerosis in gout | Q37702650 | ||
Hypertension, its treatment, hyperuricaemia and gout | Q38078199 | ||
Long-term cardiovascular mortality among middle-aged men with gout | Q38390010 | ||
Inhibition of endothelial nitric oxide synthase by C-reactive protein: clinical relevance | Q43060919 | ||
Preliminary criteria for the classification of the acute arthritis of primary gout | Q44734461 | ||
Impact of age on echocardiographic left ventricular mass in a healthy population (the Framingham Study). | Q45410953 | ||
Uric acid and left ventricular hypertrophy in Japanese men. | Q46118265 | ||
Tophaceous gout and high level of hyperuricaemia are both associated with increased risk of mortality in patients with gout. | Q51203256 | ||
Comparison of carotid arterial resistive indices with intima-media thickness as sonographic markers of atherosclerosis. | Q52930040 | ||
Renal Doppler resistance indices are associated with systemic atherosclerosis in kidney transplant recipients. | Q53851170 | ||
2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). | Q55057254 | ||
Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardio | Q57217547 | ||
Carotid intima-media thickness by B-mode ultrasound as surrogate of coronary atherosclerosis: correlation with quantitative coronary angiography and coronary intravascular ultrasound findings | Q57398791 | ||
Serum Uric Acid and Risk for Cardiovascular Disease and Death: The Framingham Heart Study | Q57740599 | ||
Gout and coronary heart disease: the Framingham Study | Q68259225 | ||
Peak early diastolic mitral annulus velocity by tissue Doppler imaging adds independent and incremental prognostic value | Q73105448 | ||
Sex differences in uric acid and risk factors for coronary artery disease | Q73989803 | ||
P433 | issue | 1 | |
P304 | page(s) | 121-130 | |
P577 | publication date | 2016-08-30 | |
P1433 | published in | Rheumatology International | Q15763689 |
P1476 | title | Evaluation of cardiovascular risk in stages of gout by a complex multimodal ultrasonography. | |
P478 | volume | 37 |
Search more.